KR101335788B1 - Method for preparing fermented extract of Gastrodiae elata by using of drip - Google Patents
Method for preparing fermented extract of Gastrodiae elata by using of drip Download PDFInfo
- Publication number
- KR101335788B1 KR101335788B1 KR1020110102546A KR20110102546A KR101335788B1 KR 101335788 B1 KR101335788 B1 KR 101335788B1 KR 1020110102546 A KR1020110102546 A KR 1020110102546A KR 20110102546 A KR20110102546 A KR 20110102546A KR 101335788 B1 KR101335788 B1 KR 101335788B1
- Authority
- KR
- South Korea
- Prior art keywords
- fermentation
- drip
- raw
- lactic acid
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000284 extract Substances 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims abstract description 27
- 238000000855 fermentation Methods 0.000 claims abstract description 95
- 230000004151 fermentation Effects 0.000 claims abstract description 95
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 86
- 239000004310 lactic acid Substances 0.000 claims abstract description 43
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 43
- 244000005700 microbiome Species 0.000 claims abstract description 35
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000002994 raw material Substances 0.000 claims abstract description 27
- 239000000203 mixture Substances 0.000 claims abstract description 24
- 238000010257 thawing Methods 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 230000001954 sterilising effect Effects 0.000 claims abstract description 17
- 241000283086 Equidae Species 0.000 claims abstract description 16
- 238000007710 freezing Methods 0.000 claims abstract description 16
- 230000008014 freezing Effects 0.000 claims abstract description 16
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 14
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 14
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 12
- 239000012153 distilled water Substances 0.000 claims abstract description 11
- 240000008042 Zea mays Species 0.000 claims abstract description 10
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 10
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 10
- 235000005822 corn Nutrition 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 10
- 239000007921 spray Substances 0.000 claims abstract description 7
- 239000005909 Kieselgur Substances 0.000 claims abstract description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 239000012535 impurity Substances 0.000 claims abstract description 5
- 238000005406 washing Methods 0.000 claims abstract description 5
- 238000010438 heat treatment Methods 0.000 claims abstract description 4
- 239000006166 lysate Substances 0.000 claims abstract description 3
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 16
- 241000186660 Lactobacillus Species 0.000 claims description 7
- 229940039696 lactobacillus Drugs 0.000 claims description 7
- 240000006439 Aspergillus oryzae Species 0.000 claims description 6
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 6
- 241000123330 Fomes fomentarius Species 0.000 claims description 6
- 241000222646 Stereum Species 0.000 claims description 6
- 241000222355 Trametes versicolor Species 0.000 claims description 6
- 241000001727 Tropicoporus linteus Species 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 5
- 241000222356 Coriolus Species 0.000 claims description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- 240000005979 Hordeum vulgare Species 0.000 claims description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 235000013681 dietary sucrose Nutrition 0.000 claims description 4
- 235000013312 flour Nutrition 0.000 claims description 4
- 229920001542 oligosaccharide Polymers 0.000 claims description 4
- 150000002482 oligosaccharides Chemical class 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 229960004793 sucrose Drugs 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 3
- SSISHJJTAXXQAX-ZETCQYMHSA-N L-ergothioneine Chemical compound C[N+](C)(C)[C@H](C([O-])=O)CC1=CNC(=S)N1 SSISHJJTAXXQAX-ZETCQYMHSA-N 0.000 abstract description 15
- 229940093497 ergothioneine Drugs 0.000 abstract description 15
- 230000008569 process Effects 0.000 abstract description 15
- 239000000463 material Substances 0.000 abstract description 9
- 239000005417 food ingredient Substances 0.000 abstract description 8
- 239000004615 ingredient Substances 0.000 abstract description 8
- 235000013376 functional food Nutrition 0.000 abstract description 6
- 230000035622 drinking Effects 0.000 abstract description 5
- 235000012041 food component Nutrition 0.000 abstract description 5
- 239000002537 cosmetic Substances 0.000 abstract description 3
- 210000001821 langerhans cell Anatomy 0.000 abstract description 3
- 239000002861 polymer material Substances 0.000 abstract description 3
- 239000000047 product Substances 0.000 description 24
- 239000000126 substance Substances 0.000 description 16
- 239000007788 liquid Substances 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 9
- 235000013305 food Nutrition 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 5
- 239000000686 essence Substances 0.000 description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 5
- 229930000044 secondary metabolite Natural products 0.000 description 5
- 244000221226 Armillaria mellea Species 0.000 description 4
- 240000000249 Morus alba Species 0.000 description 4
- 235000008708 Morus alba Nutrition 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000221198 Basidiomycota Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229930010796 primary metabolite Natural products 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000011569 Armillaria mellea Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000190633 Cordyceps Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000015728 Mucins Human genes 0.000 description 2
- 108010063954 Mucins Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 238000010364 biochemical engineering Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- ZENOXNGFMSCLLL-UHFFFAOYSA-N vanillyl alcohol Chemical compound COC1=CC(CO)=CC=C1O ZENOXNGFMSCLLL-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- PUQSUZTXKPLAPR-KSSYENDESA-N 4-(beta-D-Glucopyranosyloxy) benzyl alcohol Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-KSSYENDESA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000305491 Gastrodia elata Species 0.000 description 1
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000194022 Streptococcus sp. Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013611 frozen food Nutrition 0.000 description 1
- 229930193974 gastrodin Natural products 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- PUQSUZTXKPLAPR-NZEXEKPDSA-N helicidol Natural products O([C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-NZEXEKPDSA-N 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229940051875 mucins Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229930195732 phytohormone Natural products 0.000 description 1
- 239000002373 plant growth inhibitor Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B7/00—Preservation of fruit or vegetables; Chemical ripening of fruit or vegetables
- A23B7/02—Dehydrating; Subsequent reconstitution
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Alternative & Traditional Medicine (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
본 발명은 생천마를 주원료로 하여 세척한 다음 건조하는 제1단계; 상기 제1단계의 건조물을 급속 동결한 다음, 발효조 내에서 해동드립하여 진액을 추출하는 제2단계; 상기 제2단계의 생천마 진액을 배양조 상에서 발효미생물과 증류수와 혼합한 다음, 발효에 필요한 질소원과 탄소원을 추가하여 혼합물을 생성하는 제3단계; 상기 제3단계의 혼합물을 생물반응기(bioreactor) 상에서 생물반응을 거쳐 액상화된 젖산발효산물을 생성하는 제4단계; 상기 제4단계의 젖산발효산물을 급속멸균장치(Outoclave)를 이용하여 발효미생물을 멸균하는 제5단계; 상기 제5단계의 젖산발효산물을 규조토 여과기를 이용하여 불순물을 제거한 다음, 가열하여 25~60브릭스(Brix)를 지니도록 농축하는 제6단계; 및 상기 제6단계의 발효추출물을 스프레이 드라이어(Spray dryer)를 이용하여 수분율 5~7%를 지니도록 건조하는 제7단계;를 포함하여 이루어지는 것을 특징으로 한다.
이에 따라 본 발명은, 생천마를 급속 동결하여 해동드립(drip)하는 과정에서 나오는 진액에 발효미생물을 통한 생물반응을 거쳐 발효한 발효추출물을 취득함에 따라, 생천마의 유용성분과 에르고티오닌(Ergothioneine=ERG)이 함유된 식품원료를 비롯하여 음용원료, 의약원료, 기능성식품 원료 및 향장원료 등 자유로운 제형 변화를 쉽게 할 수 있고, 생천마의 유용성분들이 인체 친화적인 물질로 바뀌어 랑게르한스 세포가 거부감을 없애면서 천마의 고분자물질이 나노화되어 인체에 쉽게 흡수되고, 저비용으로 고부가성 물질을 대량으로 양산 가능한 효과가 있다.The present invention comprises the first step of washing and then drying with raw corn as a main raw material; A second step of rapidly freezing the dried product of the first step and then extracting the lysate by thawing drip in a fermenter; A third step of mixing the raw cheonma sake solution of the second step with the fermentation microorganism and distilled water in a culture tank, and then adding a nitrogen source and a carbon source necessary for fermentation to generate a mixture; A fourth step of producing a liquefied lactic acid fermentation product through a bioreaction of the mixture of the third step on a bioreactor; A fifth step of sterilizing the fermentation microorganism using the fourth step lactic acid fermentation product using an rapid sterilization apparatus (Outoclave); A sixth step of removing impurities from the fermented lactic acid product of the fifth step by using a diatomaceous earth filter and then heating and concentrating to have 25 to 60 brix; And a seventh step of drying the fermentation extract of the sixth step to have a moisture content of 5 to 7% using a spray dryer.
Accordingly, the present invention, by obtaining the fermentation extract fermented through the bioreaction through the fermentation microorganisms in the extract from the process of rapidly freezing the frozen horses and thawing drip (drip), useful components and ergothioneine (Ergothioneine) = ERG) containing food ingredients, drinking ingredients, medicinal raw materials, functional food ingredients and cosmetic raw materials can be easily changed freely, and the useful components of raw horses are changed to human-friendly materials, so the Langerhans cells eliminate the rejection. However, the polymer material of cheonma is nano-ized and easily absorbed by the human body, and it is possible to mass-produce high value-added materials at low cost.
Description
본 발명은 생천마를 이용하여 발효추출물을 제조하는 방법에 관한 것으로, 보다 구체적으로는 생천마를 급속 동결하여 해동드립(drip)하는 과정에서 나오는 진액에 발효미생물을 통한 생물반응을 거쳐 발효한 발효추출물을 취득하여, 생천마의 유용성분과 에르고티오닌(Ergothioneine=ERG)이 함유된 식품원료를 비롯하여 음용원료, 의약원료, 기능성식품 원료 및 향장원료 등 자유로운 제형 변화를 할 수 있는 해동드립을 이용한 생천마 발효추출물을 제조하는 방법에 관한 것이다.The present invention relates to a method for producing a fermentation extract using raw cheonma, and more specifically, fermentation fermented through a bio-reaction through fermentation microorganisms to the sediment from the process of rapidly freezing the frozen cheonma and drip The extract is obtained by using the thawing drip that can freely change the formulation, such as food ingredients containing the raw ingredients and ergothioneine (ERG) of raw horses, and drinking ingredients, medical ingredients, functional food ingredients, and fragrance raw materials. It relates to a method for producing the cheonma fermentation extract.
통상, 천마(天麻; Gastrodiae elata)는 난과에 속하는 다년생 고등식물(이 등, 2007)로 엽록소가 없어서 독자생존이 어려워 뽕나무버섯균(Armillaria mellea)과 공생(Kang, 2007; Kim 등, 2006; Sung, 1994; Sung 등, 1996; Hong 등, 2004; Kusano, 1911; Zhang 등, 1980)하면서 양분과 수분을 공급 받는 것이 밝혀져 있으며, 이후 뽕나무버섯균(Armillaria mellea)을 이용하여 천마의 인공재배(Kang 등, 2002)가 가능하게 되었다.Normally, Gastrodiae elata is a perennial higher plant belonging to the egg family (Lee et al., 2007), which lacks chlorophyll, making it difficult for independent survival, resulting in symbiosis with Armillaria mellea (Kang, 2007; Kim et al., 2006; Sung, 1994; Sung, etc., 1996; Hong, etc., 2004; Kusano, 1911; Zhang et al., 1980) and has been shown to receive supplies of food and water, the artificial cultivation of Gastrodia elata using mulberry fungus (Armillaria mellea) after ( Kang et al., 2002).
그리고 천마는 뽕나무버섯균(A. mellea)과 함께 예로부터 중국 한국에서 한약제로 귀하게 사용되어 왔고, 신 농본초본에는 상약으로 분류되고 있다. 또한 천마는 뽕나무버섯과 유사한 인체에 관한 기능이 있으며, 특히 항 혈전작용(Cho 등, 2008), 항산화작용(Heo 등, 2006), 신경전달 조절작용(Ha 등, 1997), 신경보호작용(Na 등, 2008), 인체생리조절 작용(Chung 와 Ji, 1996)이 있고, 뇌기능에 관여하는 물질이 다량 존재하여 중풍마비, 뇌졸중, 경련억제(Sung 등, 1997; Yong 등, 1999; Huh 등, 1995, 1998) 등의 뇌에 관한 한의학적으로 논문이 다수 발표되었고, 현재도 임상연구는 계속되고 있으며, 현대 의학적인 약리적 연구도 많이 이루어지고 있다. Chunma has been used as a herbal medicine in China and Korea since ancient times, along with A. mellea . In addition, cheonma has a function on the human body similar to mulberry mushroom, especially antithrombotic action (Cho et al., 2008), antioxidant activity (Heo et al., 2006), neurotransmitter control action (Ha et al., 1997), neuroprotective action (Na Et al., 2008), human physiological regulating action (Chung and Ji, 1996), and the presence of a large amount of substances involved in brain function caused paralysis, stroke, and convulsion suppression (Sung et al., 1997; Yong et al., 1999; Huh et al., 1999). 1995, 1998) and many other medical papers on the brain have been published, and clinical research continues, and many modern medical pharmacological studies have been conducted.
즉, 천마의 일반성분으로는 수분 2.12%, 조단백 4.41%, 조지방 1.20%, 조회분 2.52%, 조섬유 4.60% 이며(Kim 등, 2000; Shin 등, 1999; Ha 등, 1999), 영양성분으로는 gastrodin 0.25~0.67%, astrodiosid(ρ-hydroxybenzol), vanillyl alcohol, succinic acid, citric acid, palmitic acid, ρ-hydroxybenzyl aldenyde, 미량의 alkaloides, 비타민A 류 물질인 β-sitosterol. Coumarin 물질 등으로 구성되어 있다.(문, 1991) 이외에도, sterol류, cholesterol, ρ-hydroxylbenzyl alcohol, vanillin 등의 성분에 대하여도 알려져 있다.(Kim 등, 2000)In other words, the general components of Chunma are 2.12% moisture, 4.41% crude protein, 1.20% crude fat, 2.52% crude ash, 4.60% crude fiber (Kim et al., 2000; Shin et al., 1999; Ha et al., 1999). gastrodin 0.25 ~ 0.67%, astrodiosid (ρ-hydroxybenzol), vanillyl alcohol, succinic acid, citric acid, palmitic acid, ρ-hydroxybenzyl aldenyde, trace alkaloides, β-sitosterol as a vitamin A substance. It is composed of a coumarin substance and the like (Moon, 1991). In addition, ingredients such as sterols, cholesterol, ρ-hydroxylbenzyl alcohol, and vanillin are also known (Kim et al., 2000).
또한, 천마는 기생식물로 생육과정에 뽕나무버섯균사와 공생하는 관계로 천마 내에 A. mellea(뽕나무버섯균)이 함유(Kang, 2007; Kim 등,2000; Sung, 1994; Sung 등, 1996; Hong 등, 2004) 되어 있는데, 이는 아미노산 일종으로, 강력한 항산화제로 알려 있으며, 피부노화방지제 및 뇌혈류 흐름의 장애에 의해 나타나는 질병 등에 상업적으로 이용되는 에르고티오닌(Ergothioneine)이 미량으로 함유되어 있다.In addition, Chunma is a parasitic plant that contains A. mellea (Mulberry fungus) in Chunma as it coexists with mulberry mycelium during the growth process (Kang, 2007; Kim et al., 2000; Sung, 1994; Sung et al., 1996; Hong Et al., 2004, which is a type of amino acid, known as a powerful antioxidant, contains trace amounts of ergothioneine, which is commercially available for skin aging agents and diseases caused by disorders of cerebral blood flow.
이러한, 천마는 그동안 식품의약품 안정청의 식품불가 원료로 규제되어 오다가 2000년 9월 1일부터 식품불가 규제가 풀리게 되어(Kim 등, 2003), 식품사용 원료로 가능하게 되었다. 천마는 어떠한 물질에 의해 이러한 약성이 나타나는지 불투명하였지만, 근자에 국립 산림과학원 생물공학과, 화학미생물과의 연구에 의해 천마에 에르고티오닌(Ergothioneine=ERG)이 미량으로 함유되어 있는 것을 세계 최초로 발견되면서 천마의 귀중함이 재입증되었다. Cheonma has been regulated as a food-free raw material by the Korea Food and Drug Administration, and the food-free regulation was released from September 1, 2000 (Kim et al., 2003). Although it was unclear what kind of substance caused this weakness, Cheonma was discovered for the first time in the world by discovering trace amount of ergothioneine (ERG) in Cheonma by research by National Forest Research Institute of Biotechnology and Chemical Microbiology. Was revalidated.
이와 같이, 천마는 효과나 약성이 뛰어난 반면에 건조방법(Sung 등, 1995; Lee 등, 2003; Hong 등, 2006) 이나 추출방법(Lee 등, 2003)에 따라 좋지 못한 맛과 냄새(Kim 등, 2004; Kim 등, 2001; Lee 등, 2002; Lee 등, 2003)의 차이가 크게 변하는 관계로 식품으로 대중화하기에는 많은 문제점이 있고, 현재 공급이 수요를 충족시키지 못하고 있는 실정으로, 재배를 통한 대량생산 시대를 대비하여 대중적이고 고부가성인 건강식품의 개발이 요구되고 있는 실정이다.As such, cheonma has an excellent effect and weakness, while the taste and smell (Kim et al., 2003, Lee et al., 2003; Hong et al., 2006) or extraction method (Lee et al., 2003) are not good. 2004; Kim et al., 2001; Lee et al., 2002; Lee et al., 2003), and there are many problems to popularize them as foods, and supply is not sufficient to meet demand. In preparation for the times, the development of popular and high value-added health foods is required.
이외에도, 생천마에 함유된 진액을 이용한 가공식품개발에 관심을 기울이고 있지만, 특히 천마 진액에 함유된 전분에 의한 혼탁과, 끈적끈적한 뮤신질로 인해 가공 상에 문제가 발생되는 한편, 인체에 흡수가 느리고, 식음에 어려움이 있을 뿐만 아니라, 여러 가지 형태로 제형의 변화가 어려워 대량으로 가공하여 양산하기에 곤란하므로 이를 활용하는데 있어 그 한계성을 보이고 있다.In addition, although attention is focused on developing processed foods using the essences contained in raw corn horses, the turbidity caused by starch in cheonma essences and sticky mucins causes problems in processing, and it is slow to be absorbed by the human body. As well as difficulty in food and beverage, it is difficult to change the dosage form in various forms, so difficult to process and mass-produce in large quantities, showing its limitations in utilizing them.
상기와 같은 종래의 문제점들을 근본적으로 개선하기 위한 본 발명의 목적은, 생천마를 급속 동결하여 해동드립(drip)하는 과정에서 나오는 진액에 발효미생물을 통한 생물반응을 거쳐 발효한 발효추출물을 취득함에 따라, 생천마의 유용성분과 에르고티오닌(Ergothioneine=ERG)이 함유된 식품원료를 비롯하여 음용원료, 의약원료, 기능성식품 원료 및 향장원료 등 자유로운 제형 변화를 쉽게 할 수 있고, 생천마의 유용성분들이 인체 친화적인 물질로 바뀌어 랑게르한스 세포가 거부감을 없애면서 천마의 고분자물질이 나노화되어 인체에 쉽게 흡수되고, 저비용으로 고부가성 물질을 대량으로 양산 가능한 해동드립을 이용한 생천마 발효추출물을 제조하는 방법을 제공하려는데 있다.An object of the present invention for fundamentally improving the conventional problems as described above, to obtain a fermentation extract fermented through a biological reaction through the fermentation microorganisms to the essence from the process of freezing the frozen horses and thawing drip (drip) Accordingly, it is possible to easily change free formulations such as food ingredients containing raw yam and ergothioneine (ERG), drinking ingredients, medicinal raw materials, functional food raw materials and fragrance raw materials. Provided a method for producing fermented horses fermentation extracts using thaw drip which can be mass-produced high-value substances at low cost by releasing the resistance of Langerhans cells as nano-materials are easily absorbed by human body. I'm trying to.
상기 목적을 달성하기 위한 본 발명은, 생천마를 주원료로 하여 세척한 다음 건조하는 제1단계; 상기 제1단계의 건조물을 급속 동결한 다음, 발효조 내에서 해동드립하여 진액을 추출하는 제2단계; 상기 제2단계의 생천마 진액을 배양조 상에서 발효미생물과 증류수와 혼합한 다음, 발효에 필요한 질소원과 탄소원을 추가하여 혼합물을 생성하는 제3단계; 상기 제3단계의 혼합물을 생물반응기(bioreactor) 상에서 생물반응을 거쳐 액상화된 젖산발효산물을 생성하는 제4단계; 상기 제4단계의 젖산발효산물을 급속멸균장치(Outoclave)를 이용하여 발효미생물을 멸균하는 제5단계; 상기 제5단계의 젖산발효산물을 규조토 여과기를 이용하여 불순물을 제거한 다음, 가열하여 25~60브릭스(Brix)를 지니도록 농축하는 제6단계; 및 상기 제6단계의 발효추출물을 스프레이 드라이어(Spray dryer)를 이용하여 수분율 5~7%를 지니도록 건조하는 제7단계;를 포함하여 이루어지는 것을 특징으로 한다.The present invention for achieving the above object, the first step of washing and drying the raw horse as a main raw material; A second step of rapidly freezing the dried product of the first step and then extracting the lysate by thawing drip in a fermenter; A third step of mixing the raw cheonma sake solution of the second step with the fermentation microorganism and distilled water in a culture tank, and then adding a nitrogen source and a carbon source necessary for fermentation to generate a mixture; A fourth step of producing a liquefied lactic acid fermentation product through a bioreaction of the mixture of the third step on a bioreactor; A fifth step of sterilizing the fermentation microorganism using the fourth step lactic acid fermentation product using an rapid sterilization apparatus (Outoclave); A sixth step of removing impurities from the fermented lactic acid product of the fifth step by using a diatomaceous earth filter and then heating and concentrating to have 25 to 60 brix; And a seventh step of drying the fermentation extract of the sixth step to have a moisture content of 5 to 7% using a spray dryer.
또, 본 발명에 따르면 상기 제2단계는 건조물을 -40℃~-70℃로 유지하여 4~30시간 급속 동결하고, 발효조 내에서 25℃~60℃로 유지하여 해동드립(drip)을 진행하는 것을 특징으로 한다.In addition, according to the present invention, the second step is to rapidly freeze 4 to 30 hours by maintaining the dried product at -40 ° C. to −70 ° C., and maintaining the temperature at 25 ° C. to 60 ° C. in the fermenter to perform a defrost drip. It is characterized by.
또한, 본 발명에 따르면 상기 제3단계는 생천마 진액에 발효미생물인 구름버섯(Coriolus versicolor), 꽃구름버섯(Stereum hirustum), 상황버섯(Phellinus linteus), 누룩곰팡이(Aspergillus oryzae), 말굽버섯(Fomes fomentarius), 동충하초(Coriolus sinensis), 바실러스(Bacillus)속, 락토바실러스(Lactobacillus)속을 그람(g)당 개체수가 의 개체수가 되도록 배양시켜 증류수와 혼합하여 pH 5.5~7을 지니도록 한 다음, 질소원과 탄소원 5~50중량%를 추가하여 혼합물을 생성하는 것을 특징으로 한다.In addition, according to the present invention, the third step is a fermented microorganism cloud (Coriolus versicolor), mushroom cloud (Stereum hirustum), mushroom (Phellinus linteus), yeast fungus (Aspergillus oryzae), horseshoe mushrooms Population per gram (g) in Fomes fomentarius, Coriolus sinensis, Bacillus genus, and Lactobacillus genus After culturing to a number of individuals to be mixed with distilled water to have a pH of 5.5 ~ 7, and then add a nitrogen source and 5 to 50% by weight carbon source, characterized in that to produce a mixture.
또한, 본 발명에 따르면 상기 제3단계의 질소원은 미강, 보리가루, 밀기울 중에서 1종을 택일하고, 탄소원은 사카로스, 말로즈, 올리고당 중에서 1종을 택일하여 생물반응이 잘 이루어지도록 혼합한 것을 특징으로 한다.In addition, according to the present invention, the nitrogen source of the third step may be one selected from rice bran, barley flour, and bran, and the carbon source is one selected from saccharose, malose, and oligosaccharide, and mixed so that bioreaction is performed well. It features.
또한, 본 발명에 따르면 상기 제4단계는 혼합물을 생물반응기의 온도 18℃~50℃와, pH 5.5~7을 유지하는 무압의 조건 하에서 2~60일간 생물반응으로 발효하여 액상화된 젖산발효산물을 생성하는 것을 특징으로 한다.In addition, according to the present invention, in the fourth step, the mixture is fermented by bioreaction for 2 to 60 days under a pressureless condition of maintaining a temperature of 18 ° C. to 50 ° C. and a pH of 5.5 to 7 of the bioreactor, thereby liquefying the lactic acid fermented product. It is characterized by generating.
또한, 본 발명에 따르면 상기 제5단계는 젖산발효산물을 급속멸균장치(Outoclave)를 이용하여 121℃~132℃의 온도로 10~30분간 생물반응시 투입된 발효미생물을 멸균하는 것을 특징으로 한다.In addition, according to the present invention, the fifth step is characterized by sterilizing the fermentation microorganisms added during the bioreaction 10 to 30 minutes at a temperature of 121 ℃ ~ 132 ℃ using a lactic acid fermentation product sterilization (Outoclave).
한편, 이에 앞서 본 명세서 및 특허청구범위에 사용된 용어나 단어는 통상적이거나 사전적인 의미로 한정해서 해석되어서는 아니 되며, 발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야만 한다. 따라서 본 명세서에 기재된 실시예와 도면에 도시된 구성은 본 발명의 가장 바람직한 일 실시예에 불과할 뿐이고, 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형예들이 있을 수 있음을 이해하여야 한다.It should be understood, however, that the terminology or words of the present specification and claims should not be construed in an ordinary sense or in a dictionary, and that the inventors shall not be limited to the concept of a term It should be construed in accordance with the meaning and concept consistent with the technical idea of the present invention based on the principle that it can be properly defined. Therefore, the embodiments described in the present specification and the configurations shown in the drawings are merely the most preferred embodiments of the present invention, and not all of the technical ideas of the present invention are described. Therefore, It is to be understood that equivalents and modifications are possible.
이상의 구성 및 작용에서 설명한 바와 같이, 본 발명에 의한 해동드립을 이용한 생천마 발효추출물을 제조하는 방법은 생천마를 급속 동결하여 해동드립(drip)하는 과정에서 나오는 진액에 발효미생물을 통한 생물반응을 거쳐 발효한 발효추출물을 취득함에 따라, 생천마의 유용성분과 에르고티오닌(Ergothioneine=ERG)이 함유된 식품원료를 비롯하여 음용원료, 의약원료, 기능성식품 원료 및 향장원료 등 자유로운 제형 변화를 쉽게 할 수 있는 효과를 제공한다.As described in the above configuration and operation, the method for producing a fermented horse cheonja fermentation extract using the thawed drip according to the present invention is a bio-reaction through the fermentation microorganisms to the essences from the process of freezing the frozen cheonja by drip By acquiring fermented extracts fermented through, it is possible to easily change free formulation such as food raw materials containing raw yam and ergothioneine (ERG), drinking raw materials, medical raw materials, functional food raw materials and cosmetic raw materials. Provide the effect.
또한, 생천마의 유용성분들이 인체 친화적인 물질로 바뀌어 랑게르한스 세포가 거부감을 없애면서 천마의 고분자물질이 나노화되어 인체에 쉽게 흡수되고, 저비용으로 고부가성 물질을 대량으로 양산 가능한 효과를 제공한다.In addition, the useful components of live horses are turned into human-friendly materials, so that Langerhans cells are rejected and the polymers of the horses are nano-ized to be easily absorbed by the human body, and provide mass-producing high-added substances at low cost.
도 1은 본 발명에 의한 생천마를 이용하여 발효추출물을 제조하기 위한 전체적인 흐름도.
도 2는 생천마를 이용하여 발효추출물을 제조과정을 나타낸 사진.1 is an overall flow chart for producing a fermentation extract using raw corn horse according to the present invention.
Figure 2 is a photograph showing the process of producing a fermented extract using raw corn.
이하, 첨부된 도면을 참조하여 본 발명에 따른 바람직한 실시예를 상세하게 설명한다.Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings.
본 발명은 생천마를 이용하여 발효추출물을 제조하는 방법에 관련되며, 즉 생천마를 급속 동결하여 해동 드립 후 생물반응을 통한 발효미생물을 이용하여 발효추출물을 취득하는 방법에 관한다. 이러한 방법을 간략하게 설명하면 세척, 건조, 급속 동결, 해동드립, 발효미생물 투입, 생물반응에 의한 액체발효, 멸균, 여과, 농축, 건조단계를 거쳐 발효추출물을 제조한다.The present invention relates to a method for producing a fermentation extract using raw cheonma, ie, a method of obtaining a fermentation extract by using a fermentation microorganism through a bioreaction after thawing drip by freezing the raw cheonma. Briefly describing this method, the fermentation extract is prepared by washing, drying, rapid freezing, thawing drip, fermentation microorganisms, liquid fermentation by bioreaction, sterilization, filtration, concentration, and drying.
본 발명의 제1단계는 생천마를 주원료로 하여 세척한 다음 건조한다. 제1단계는 주원료를 세척 및 건조하는 단계로, 생천마를 주원료로 하여 세척 및 건조한다. 이는 생천마를 물에 깨끗이 세척하고, 세척시 잔존하는 수분을 건조하며, 품질 안정과 생산성 향상을 위한 자동화 장치를 도입한다. 여기서, 이러한 제1단계에서 건조과정은 세척된 생천마의 겉의 물기가 마를 수 있도록 제공한다.The first step of the present invention is washed with dried raw horse as the main raw material and then dried. The first step is to wash and dry the main raw material, which is washed and dried using raw corn as the main raw material. It cleans raw corn horses in water, dries the remaining water during washing, and introduces an automatic device for quality stability and productivity improvement. Here, the drying process in the first step is provided to dry the outer surface of the washed raw spring horse.
본 발명의 제2단계는 상기 제1단계의 건조물을 급속 동결한 다음, 발효조 내에서 해동드립하여 진액을 추출한다. 제2단계는 건조단계를 거친 주원료(건조물)를 급속 동결한 다음 해동드립하는 단계로, 특히 주원료를 급속 동결 및 해동드립함에 있어서 생산성 향상 및 품질 안정을 위해 전용의 자동화 설비를 도입하는 것이 좋다. In the second step of the present invention, the freeze-dried product of the first step is rapidly frozen, and then thawed and drip in a fermenter to extract the extract. The second step is to freeze and then thaw the main raw material (dried) after the freezing step, particularly in the rapid freezing and thawing of the main raw material, it is recommended to introduce a dedicated automated equipment for improved productivity and quality stability.
이때, 상기 제2단계는 건조물을 -40℃~-70℃로 유지하여 4~30시간 급속 동결하고, 발효조 내에서 25℃~60℃로 유지하여 해동드립(drip)을 진행한다. 이는 건조된 주원료, 즉 생천마를 1차적으로 -40℃~-70℃에서 급냉을 시행하고 4~30시간 급속으로 동결작업한다. 이어서, 2차적으로 동결된 생천마를 25℃~60℃로 유지하는 발효조를 이용하여 해동드립을 진행하여 생천마 내에서 진액을 자연 추출한다.(도 2)At this time, the second step is to keep the dried material at -40 ℃ ~ -70 ℃ rapid freezing for 4 to 30 hours, the thawing drip (drip) by maintaining at 25 ℃ ~ 60 ℃ in the fermenter. It quenched the dried main raw material, ie, raw horse, at -40 ℃ ~ -70 ℃ and freezes rapidly for 4 ~ 30 hours. Subsequently, thawing drips are carried out using a fermentation tank that maintains the frozen frozen horses at 25 ° C. to 60 ° C. to naturally extract the essences from the frozen horses (FIG. 2).
여기서, 해동드립(drip)은 냉동한 식품을 해동하였을 때 분리 유출하는 액즙. 드립은 해동시 자연스럽게 유출하는 유출액 드립과 해동종료시에 압력(1~2kg/cm2)을 걸어 유출하여 나오는 압출액 드립으로 구별되는데, 양자를 합쳐서 총 드립이라고 한다. 드립은 식품을 냉동하였을 때의 빙결정의 생성에 따르는 조직의 파괴나 단백질의 냉동변성 등에 의해서 해동시에 식품 중에 수분이 유지되기 어렵게 되기 때문에 생긴다. 드립에는 물과 동시에 수용성 단백질이나 엑기스분이 함유되어 있다. 이러한 해동드립양은 동결속도와 해동속도에 영향을 받는다. Here, the thawing drip (drip) is the juice that is separated and discharged when thawing frozen food. Drips are divided into effluent drips that naturally flow out during thawing and extruded liquid drips that flow out by applying pressure (1-2 kg / cm2) at the end of thawing. Drips occur because moisture is hardly retained in the food during thawing due to tissue breakdown or freezing denaturation of proteins caused by the formation of ice crystals when the food is frozen. Drips contain water-soluble proteins and extracts at the same time as water. The amount of thawing drips is affected by freezing rate and thawing rate.
본 발명의 제3단계는 상기 제2단계의 생천마 진액을 배양조 상에서 발효미생물과 증류수와 혼합한 다음, 발효에 필요한 질소원과 탄소원을 추가하여 혼합물을 생성한다. 제3단계는 제2단계의 해동드립으로 추출된 생천마 진액에 발효미생물, 증류수, 발효에 필요한 산물을 혼합하여 혼합물을 생성하는 단계로, 품질 안정과 생산성 향상을 위해 해당 공정을 자동화한다.In the third step of the present invention, after mixing the fermented saline solution of the second step with the fermentation microorganism and distilled water in the culture tank, a nitrogen source and carbon source necessary for fermentation are added to generate a mixture. The third step is to produce a mixture by mixing fermentation microorganisms, distilled water, and the products required for fermentation in the raw cheonma juice extracted by the thawing drip of the second step, and to automate the process for quality stability and productivity improvement.
이때, 상기 제3단계는 생천마 진액에 발효미생물인 구름버섯(Coriolus versicolor), 꽃구름버섯(Stereum hirustum), 상황버섯(Phellinus linteus), 누룩곰팡이(Aspergillus oryzae), 말굽버섯(Fomes fomentarius), 동충하초(Coriolus sinensis), 바실러스(Bacillus)속, 락토바실러스(Lactobacillus)속을 그람(g)당 개체수가 의 개체수가 되도록 배양시켜 증류수와 혼합하여 pH 5.5~7을 지니도록 한 다음, 질소원과 탄소원 5~50중량%를 추가하여 혼합물을 생성한다. 또한, 상기 제3단계의 질소원은 미강, 보리가루, 밀기울 중에서 1종을 택일하고, 탄소원은 사카로스, 말로즈, 올리고당 중에서 1종을 택일하여 생물반응이 잘 이루어지도록 혼합한다.At this time, the third step is fermented microorganisms of fermented microorganisms (Coriolus versicolor), cloud mushroom (Stereum hirustum), mushroom (Phellinus linteus), yeast fungus (Aspergillus oryzae), horseshoe (Fomes fomentarius), Number of individuals per gram (g) in Cordyceps (Coriolus sinensis), Bacillus genus, and Lactobacillus genus Incubate so that the population of water to be mixed with distilled water to have a pH of 5.5-7, and then add a nitrogen source and 5 to 50% by weight of a carbon source to produce a mixture. In addition, the nitrogen source of the third step is selected from one of the rice bran, barley flour, bran, and the carbon source is selected from saccharose, malose, oligosaccharides and mixed to facilitate the bioreaction.
이는 생천마 진액을 액상화하기 위해 발효미생물 중 유용성이 입증된 버섯균주와 유산균을 이용하여 증류수와 혼합한 다음 질소원과 탄소원을 혼합하여 생물반응이 잘 이루어지도록 한다. 즉, 액상화된 발효산말을 생성하기 위해 생천마 진액에 1차적으로 배양조(급속배양기인 쉐이킹 인큐베이터)상에 상기의 발효미생물을 그람(g)당 개체수가 의 개체수가 되도록 대량으로 배양한 다음 증류수와 서로 혼합하여 pH 5.5~7을 지닌 혼합물을 생성한다. 이어서 발효에 필요한 질소원과 탄소원에서 1종을 택일하여 각각 5~50중량%를 추가하여 고루 잘 섞어주어 혼합물을 생성한다.This is a mushroom strain and lactic acid bacteria proved to be useful among fermented microorganisms to liquefy the fresh cheonma juice to be mixed with distilled water and then a nitrogen source and a carbon source to ensure a good biological reaction. In other words, the number of individuals per gram (g) of the fermentation microorganisms in the culture tank (shaking incubator, a rapid incubator) to the cheoncheon horse concentrate to produce a liquefied fermentation powder. Incubate in large quantities so that the population of and then mix with distilled water to produce a mixture with a pH of 5.5-7. Subsequently, one of the nitrogen and carbon sources required for fermentation is selected, and 5 to 50% by weight of each is added and mixed well to produce a mixture.
한편, 미생물로 사용되는 담자균류가 생성하는 2차대사산물에는 다른 균류에는 볼 수 없는 특징을 가지고 있다. 즉, 미생물인 Coriolus versicolor, Stereum hirustum, Phellinus linteus, Aspergillus oryzae, Fomes fomentarius, Coriolus sinensis은 많은 대사산물을 가지고 있다. 이는 1차대사산물은 생물의 생존에 필수적인 물질로서 생리적 의의는 밝혀져 있으나 2차 대사산물의 의의는 아직 불명확하다. 외적에 대한 방어물질로서 항생물질로 연구가 되고 있으며, 생리활성에 대한 산물로 항 종양성 다당류, 항바이러스 물질, 항균성 물질, 효소저해제, 핵산관련물질, 아미노산 관련물질, 유기산, 식물 호르몬류, 그 외의 생리활성 물질로 펩타이드나 단백질계의 생리활성 물질들로 곤충, 선충, 점균 등에 작용하는 물질, 식물 생육저해물질, 비타민 B1 파쇄물질, 약리활성 물질 등 아직도 밝혀지지 않는 많은 부분들이라고 볼 수 있다. On the other hand, secondary metabolites produced by basidiomycetes used as microorganisms have characteristics that are not found in other fungi. In other words, the microorganisms Coriolus versicolor, Stereum hirustum, Phellinus linteus, Aspergillus oryzae, Fomes fomentarius, and Coriolus sinensis have many metabolites. The primary metabolites are essential for the survival of living organisms, but their physiological significance has been revealed, but the significance of secondary metabolites is still unclear. Antimicrobials, antimicrobials, enzymatic inhibitors, nucleic acid-related substances, amino acid-related substances, organic acids, phytohormones, and the like. Other physiologically active substances are peptides and protein-based physiologically active substances, which are still unknown, such as substances acting on insects, nematodes, germs, plant growth inhibitors, vitamin B1 breakdown substances and pharmacologically active substances .
그리고 유산균은 당류(糖類)를 분해하여 젖산을 만드는 작용(젖산발효)을 하는 세균의 총칭으로, 젖산발효를 일으키는 중요한 세균은 공 모양인 스트렙토코쿠스속(屬)과 막대모양인 락토바실루스속이다. 모두가 그램 양성이고 통성혐기성(通性嫌氣性)이다. 젖산발효에서는 6탄당 분자에서 2분자의 젖산이 생기는데, 이때 거의 부산물을 수반하지 않는 경우와 젖산 외에 알코올ㆍ아세트산ㆍ호박산ㆍ이산화탄소 등의 부산물을 수반하는 경우가 있다. 앞의 것을 정상 젖산발효 또는 호모젖산발효라고 하고, 여기에 관여하는 세균을 정상 젖산균이라 한다. 뒤에 것을 이형(異型)젖산발효 또는 헤테로젖산발효라고 하며, 여기에 관여하는 세균을 이형젖산균이라고 한다.Lactobacillus is a generic term for bacteria that break down sugars (lactic acid) to make lactic acid (lactic acid fermentation), and important bacteria that cause lactic acid fermentation are Streptococcus sp. And rod-shaped Lactobacillus genus. All are Gram-positive and painless anaerobic. In lactic acid fermentation, two molecules of lactic acid are produced from the hexose molecule, which may be accompanied by byproducts such as alcohol, acetic acid, succinic acid and carbon dioxide in addition to lactic acid. The former is called normal lactic acid fermentation or homo lactic acid fermentation, and the bacteria involved in this are called normal lactic acid bacteria. The latter is called heterolactic acid fermentation or heterolactic acid fermentation, and the bacteria involved in this are called heterolactic acid bacteria.
본 발명의 제4단계는 상기 제3단계의 혼합물을 생물반응기(bioreactor) 상에서 생물반응을 거쳐 액상화된 젖산발효산물을 생성한다. 제4단계는 혼합물을 생물반응기 상에서 발효미생물 및 발효에 필요한 산물(질소원, 탄소원)과 생물반응을 거쳐 발효하여 액상화된 젖산발효산물을 생성하는 단계로, 품질 안정을 위해 해당 공정을 자동화한다. In the fourth step of the present invention, the mixture of the third step is bioreacted on a bioreactor to produce a liquefied lactic acid fermentation product. In the fourth step, the mixture is fermented through a bioreactor and a fermentation microorganism and a product (nitrogen source, carbon source) necessary for fermentation to produce a liquefied lactic acid fermentation product, and the process is automated for quality stability.
여기서, 말하는 액상화 젖산발효를 위한 생물반응기(bioreactor)는 생물반응의 적합한 온도범위는 10℃ 내지 60℃도정도이며, 살균된 연속교반식 생물반응기를 말한다. 생물반응기의 부피기준은 76%는 무 교반, 무 살균, 또는 호기성으로 설계된 것들이 사용되고 있으며, 무균유지가 가능한 생물반응기는 10%에 불가하다. 무균성 생물반응기는 항생제등의 고부가가치 산물에만 이용되고 있다. 본 발명에 사용되는 생물반응기(bioreactor)는 반응이 끝난 다음, 급속 멸균 단계가 따르기 때문에 무 교반, 무 살균, 또는 호기성으로 설계된 것들을 사용하여 편리하고 저렴한 생물반응 작업을 제공한다.Here, the bioreactor for liquefied lactic acid fermentation (bioreactor) is a suitable temperature range of the bioreaction is about 10 ℃ to 60 ℃ degree, refers to a sterilized continuous stirring bioreactor. In terms of the volume of bioreactor, 76% are designed to be non-agitated, non-sterilized, or aerobic. Bioreactors capable of maintaining sterility are not available at 10%. Aseptic bioreactors are used only for high value crops such as antibiotics. The bioreactor used in the present invention provides a convenient and inexpensive bioreactor operation using those designed to be non-agitated, non-sterilized, or aerobic since the reaction is followed by a rapid sterilization step.
이때, 상기 제4단계는 혼합물을 생물반응기의 온도 18℃~50℃와, pH 5.5~7을 유지하는 무압의 조건 하에서 2~60일간 생물반응으로 발효하여 액상화된 젖산발효산물을 생성한다. 이는 혼합물을 무압의 조건 하에서 온도 18℃~50℃, pH 5.5~7이 자동으로 관리되는 생물반응기에 투입하여 2~60일간 발효미생물인 구름버섯(Coriolus versicolor), 꽃구름버섯(Stereum hirustum), 상황버섯(Phellinus linteus), 누룩곰팡이(Aspergillus oryzae), 말굽버섯(Fomes fomentarius), 동충하초(Coriolus sinensis), 바실러스(Bacillus)속, 락토바실러스(Lactobacillus)속이 원활한 생물반응을 거쳐 젖산발효를 유도하여 유용물질이 생성되도록 하여 액상화된 젖산발효산물을 생성한다. 여기서, 액상화(액체)발효단계는 생물공정 응용분야에 대표적으로 상용되는 작업인 물질재료분야인 생분해 가능한 식품 부가물, 미네랄추출물과 유사한 작업이 진행된다.(도 2)At this time, in the fourth step, the mixture is fermented by bioreaction for 2 to 60 days under a pressureless condition of maintaining the temperature of the bioreactor at 18 ° C. to 50 ° C. and pH 5.5 to 7 to produce a liquefied lactic acid fermentation product. The mixture was put into a bioreactor with a temperature of 18 ° C. to 50 ° C. and a pH of 5.5 to 7 under pressureless conditions, and fermented microorganisms (Coriolus versicolor), mushroom cloud (Stereum hirustum), Phellinus linteus, yeast fungus (Aspergillus oryzae), horseshoe mushroom (Fomes fomentarius), cordyceps (Coriolus sinensis), genus Bacillus, Lactobacillus genus induces lactic acid fermentation and useful The material is produced to produce liquefied lactic acid fermentation products. Here, the liquefaction (liquid) fermentation step is a process similar to the biodegradable food additives, mineral extracts, which is a material material field that is typically used for biological process applications (Fig. 2).
한편, 본 발명에 사용하고자 하는 담자균류, 유산균은 특히 2차 대사산물에 있어서 화학구조의 다양성과 종의 풍부함으로 인하여 산업적으로 가장 중요한 미생물로 인식되어 있다. 물질대사산물은 1차 대사산물, 2차대사산물로 나뉘며, 1차대사산물이란 동, 식물, 미생물에 보편적으로 들어 있는 가공 아미노산, 당질, 지질, 핵산 등 생체유지에 기본적인 역할을 하는 물질을 말하며, 2차대사산물은 주로 식물, 미생물에서 나타나는 알칼로이드, 테르펜, 플라보노이드, 항생물질 등의 다양한 화합물로 이들은 약용, 향료, 향장원료, 기능성 식품의 원료 등에 유용한 물질로 부각되고 있다. 앞으로도 담자균류, 유산균은 새로운 균주의 분리, 유전자 기능 등을 통하여 생물소재 산업의 중요한 위치를 차지하고 있다.On the other hand, basidiomycetes, lactic acid bacteria to be used in the present invention is recognized as the most important microorganisms in the industry due to the diversity of chemical structure and species, especially in secondary metabolites. Metabolites are classified into primary metabolites and secondary metabolites. Primary metabolites are substances that play a fundamental role in living organisms such as processed amino acids, saccharides, lipids, and nucleic acids that are commonly found in plants, plants, and microorganisms , Secondary metabolites are various compounds such as alkaloids, terpenes, flavonoids and antibiotics, which are mainly found in plants and microorganisms, and they are becoming useful as medicines, fragrances, raw materials for flavor and functional foods and the like. Basidiomycetes and lactic acid bacteria continue to occupy an important position in the biomaterials industry through isolation of new strains and gene function.
본 발명의 제5단계는 상기 제4단계의 젖산발효산물을 급속멸균장치(Outoclave)를 이용하여 발효미생물을 멸균한다. 제5단계는 액상화된 젖산발효산물을 멸균하는 단계로, 특히 젖산발효산물을 멸균함에 있어 품질 안정과 생산성 향상을 위해 전용의 자동화 설비를 도입하는 것이 좋다. The fifth step of the present invention sterilizes the fermentation microorganisms using the rapid sterilization (Outoclave) of the lactic acid fermentation product of the fourth step. The fifth step is a step of sterilizing the liquefied lactic acid fermentation product, especially in the sterilization of the lactic acid fermentation product, it is recommended to introduce a dedicated automated equipment to improve the quality and productivity.
이때, 상기 제5단계는 젖산발효산물을 급속멸균장치(Outoclave)를 이용하여 121℃~132℃의 온도로 10~30분간 생물반응시 투입된 발효미생물을 멸균한다. 이는 액상 발효과정을 거친 젖산발효산물을 급속멸균장치(Outoclave)를 이용하여 121℃~132℃의 온도로 10~30분간 생물반응시 투입된 발효미생물인 구름버섯(Coriolus versicolor), 꽃구름버섯(Stereum hirustum), 상황버섯(Phellinus linteus), 누룩곰팡이(Aspergillus oryzae), 말굽버섯(Fomes fomentarius), 동충하초(Coriolus sinensis), 바실러스(Bacillus)속, 락토바실러스(Lactobacillus)속을 멸균한다.At this time, the fifth step sterilize the fermentation microorganisms put during the bioreaction 10 to 30 minutes at a temperature of 121 ℃ ~ 132 ℃ using a lactic acid fermentation product sterilization (Outoclave). This is a fermented microorganism that has been put into the bioreactor for 10 ~ 30 minutes at the temperature of 121 ℃ ~ 132 ℃ using the liquid sterilization process (Outoclave), which is a fermentation microorganism (Coriolus versicolor) and cloud mushroom (Stereum). Sterilize hirustum, Phellinus linteus, yeast fungus (Aspergillus oryzae), horseshoe mushroom (Fomes fomentarius), Cordiolus sinensis, Bacillus genus, and Lactobacillus genus.
한편, 통상 급속 멸균이라 하면 온도 121도℃에서 10분~30분간, 132℃에서 10분~30분이 사용되고 있으나, 본 발명에서는 무살균, 또는 호기성으로 설계된 생물반응기(bioreactor)를 사용하므로 이보다 처리온도가 121℃~132℃의 온도에서 시간이 긴 10~30분 동안 처리하는 것을 효과적이다.On the other hand, in the case of rapid sterilization, 10 minutes to 30 minutes at a temperature of 121 ° C., 10 minutes to 30 minutes are used at 132 ° C., but in the present invention, a bioreactor designed to be sterilized or aerobic is used, so the treatment temperature is higher. It is effective to treat for a long time 10-30 minutes at a temperature of 121 ℃ ~ 132 ℃.
본 발명의 제6단계는 상기 제5단계의 젖산발효산물을 규조토 여과기를 이용하여 불순물을 제거한 다음, 가열하여 25~60브릭스(Brix)를 지니도록 농축한다. 제6단계는 액상화된 젖산발효산물을 여과 및 농축하는 단계로, 특히 젖산발효산물을 여과 및 농축함에 있어서 생산성 향상을 위해 전용의 자동화 설비를 도입하는 것이 좋다. 이는 젖산발효산물을 1차적으로 규조토 여과기를 이용하여 생물반응이 완료된 생천마에 함유되어있는 고분자물질(전분)의 혼탁을 방지하여 투명한 생천마 진액을 얻기 위해 불순물을 여과한 다음, 2차적으로 증발 농축(evaporation)방법을 이용하여 고형분의 함량 25~60 Brix를 지니도록 농축한다.In the sixth step of the present invention, the lactic acid fermentation product of the fifth step is removed by using a diatomaceous earth filter, and then heated and concentrated to have 25 to 60 brix. The sixth step is the step of filtering and concentrating the liquefied lactic acid fermentation product, particularly, it is preferable to introduce a dedicated automated equipment for improving productivity in filtering and concentrating the lactic acid fermentation product. The lactic acid fermentation product is first filtered by using diatomaceous earth filter to prevent turbidity of the polymer material (starch) contained in the raw fish which has completed the bioreaction, and then filtering the impurities to obtain a clear raw horse powder. Concentrate to have a solids content of 25-60 Brix using evaporation.
즉, 발효가 완료된 액상 젖산발효산물은 많은 부유물질과 불투명한 액체상태의 물질로 되어 있기 때문에 규조토 여과기를 이용하여 불순물을 거의 여과시켜 고형분이 투명한 수용성 물질의 상태를 유지한다. 이어서, 액상 젖산발효산물을 농축하는데, 농축(Concentration)이라 함은 용액으로부터 용매를 제거하여 용액의 농도를 높여주는 조작으로 증발 농축(evaporation)방법으로 용액을 비점(끓는점)까지 가열하여, 기화에 의하여 용액으로부터 수분을 제거하는 방법으로 고형분의 함량이 25~60 Brix로 농축하여 발효추출물을 제공한다.(도 2)That is, the fermented liquid lactic acid fermentation product is composed of many suspended substances and opaque liquid substances, so that impurities are almost filtered through a diatomaceous earth filter to maintain a state of a transparent water-soluble substance. Subsequently, the liquid lactic acid fermentation product is concentrated. Concentration is an operation of increasing the concentration of the solution by removing the solvent from the solution, and heating the solution to the boiling point (boiling point) by evaporation. By the method of removing moisture from the solution by the solid content of 25 ~ 60 Brix concentrated to provide a fermentation extract. (Fig. 2)
본 발명의 제7단계는 상기 제6단계의 발효추출물을 스프레이 드라이어(Spray dryer)를 이용하여 수분율 5~7%를 지니도록 건조한다. 제7단계는 농축된 발효추출물을 건조하는 단계로, 농축된 발효추출물을 건조함에 있어서 생산성 향상을 위해 전용의 자동화 설비를 도입하는 것이 좋다. 이는 농축된 발효추출물을 저장, 포장, 수송 등의 경비를 절감하고 액체부피를 줄여 가용성 성분의 농도를 높여 응용범위를 높이고, 넓혀 용도를 다양화시키고 저장성을 향상시키기 위해 함수분율이 5~7%가 되도록 스프레이 건조 분말로 제조한다. In the seventh step of the present invention, the fermentation extract of the sixth step is dried to have a moisture content of 5 to 7% using a spray dryer. The seventh step is to dry the concentrated fermentation extract, it is good to introduce a dedicated automated equipment for improving productivity in drying the concentrated fermentation extract. The water content is 5 ~ 7% to reduce the cost of storing, packing, and transporting the concentrated fermented extract, reducing the liquid volume, increasing the concentration of soluble components, increasing the range of application, diversifying the use, and improving storage. It is prepared as a spray dried powder.
즉, 농축된 발효추출물을 스프레이 드라이어 분말로 건조함에 따라 저장, 포장, 수송 등의 경비를 절감하면서 액체부피를 줄여 가용성 성분의 농도를 높여 응용범위를 높이고, 향장원료 ,식품원료 및 의약원료에 활용할 수 있는 등 용도를 다양화시키고, 저장성을 향상하여 최적의 효용을 제공한다.In other words, as the concentrated fermented extract is dried with a spray dryer powder, it reduces the volume of storage, packaging, transportation, etc. while reducing the liquid volume to increase the concentration of soluble components, increasing the scope of application, and to be used in cosmetic raw materials, food raw materials and pharmaceutical raw materials. It is possible to diversify the use and improve the shelf life to provide the optimum utility.
상기와 같이 액체발효의 생물반응 단계를 포함하는 것은 발효함에 따라, 생천마를 이용하여 해동드립하여 제조된 발효추출의 용도에 있어서, 생천마의 고분자물질로 이루어진 진액을 맑고 투명한 물질을 얻을 수 있으며, 유효 물질의 분자의 사슬을 나노단위의 적은 단위로 만들고 천마에 미량으로 함유되어 있는 에르고티오닌(Ergothioneine=ERG) 조성물을 인체에 유용하게 이용되며, 향장원료로 사용할 시 피부모공으로 흡수가 되어 피부노화를 억제하고, 음용시 장내에 흡수되어 뇌혈류에 작용을 빠르게 만들어 유효 성분이 인체에 더욱 효과적인 작용을 제공하고, 이외에도 식품원료, 의약원료 및 기능성식품 원료 등에도 병용할 수도 있다.Including the biological reaction step of liquid fermentation as described above, as the fermentation, in the use of fermentation extract prepared by thawing drip using raw cheonma, can obtain a clear and transparent material of the liquid made of the raw material of the cheoncheonma The ergothioneine (ERG) composition, which contains small amounts of molecules in the chain of the active substance and is contained in trace amounts in cheonma, is useful for the human body. When used as a cosmetic ingredient, it is absorbed into the skin pores. It inhibits skin aging and is absorbed into the intestine during drinking, which speeds up the action of cerebral blood flow, so that the active ingredient provides a more effective effect on the human body, and may also be used in combination with food ingredients, pharmaceutical ingredients, and functional food ingredients.
이와 같이, 본 발명의 발효추출물을 제조하는 방법은 생천마에 함유되어 있는 진액을 기계적인 방법을 통하여 파쇄나 착즙 등을 통하지 않고 생천마를 급속동결하여 해동하는 과정에서 드립이 일어날 수 있도록 만들고 드립과정에 흘러나오는 생천마 진액을 얻기 위해 먼저 생천마를 깨끗이 세척하고 세척된 생천마의 겉의 물기가 마를 수 있도록 건조한 다음 급속동결이 되도록 -40℃~-70℃에서 급냉하고 4~30시간 동결작업을 마친 다음 동결된 생천마를 발효조 내에서 25℃~60℃상에서 해동드립(drip)을 유도하고 드립(drip)시 흘러나오는 생천마의 추출물에 미생물을 그람(g)당 개체수가 의 개체수가 되도록 배양시켜 증류수와 혼합한 뒤, pH 5.5~7 발효에 필요한 질소원은 미강, 보리가루, 밀기울 중 1종을 택하고 탄소원으로 사카로스, 말로즈, 올리고당 등에서 1종을 택하여 5~50중량%가 되게 투입하여 천마에 함유되어있는 고분자물질(전분)의 혼탁을 방지하여 투명한 천마진액을 추출할 수 있고, 천마가공에서 문제가 되는 끈적한 뮤신질을 해결하므로 고부가성이며, 좋은 품질의 발효추출액을 제공하는데 기술의 중요성이 있다. As described above, the method for preparing the fermented extract of the present invention allows the drip to occur in the process of thawing by rapidly freezing the raw horse horse without crushing or squeezing the juice contained in the raw horse horse through mechanical methods. In order to get the raw horse sediment flowing into the process, first clean the raw horses, dry them to dry the outer surface of the washed horses, and then quench them at -40 ℃ ~ -70 ℃ to freeze quickly and freeze for 4 ~ 30 hours. After completion of the work, frozen frozen horses induce the thawing drips in the fermenter at 25 ℃ ~ 60 ℃, and the number of microorganisms per gram (g) in the extract of raw horses which flows out during the drip. After culturing to the number of individuals and mixing with distilled water, the nitrogen source required for fermentation pH 5.5-7 is selected from one of rice bran, barley flour, bran, and one selected from saccharose, malose, oligosaccharide, etc. as carbon source. It can be added to 50% by weight to prevent turbidity of the polymer material (starch) contained in the cheonma, to extract the transparent cheon margin solution, and to solve the sticky mucin quality, which is a problem in the cheonma processing, high added value, good quality Technology is important in providing fermentation extracts.
다시 설명하면, 급속동결된 생천마를 발효조 내에서 25℃~60℃상에서 해동드립(drip) 과정에 발효미생물을 첨가하여 1차적으로 심부배양작업하고, 2차적으로 생물반응기에서 액체반응을 통하여 젖산발효를 유도하여, 생천마에서 흘러나오는 진액의 고분자물질을 나노물질로 변환하는 생물공정과정을 거친다. 1, 2차의 생물공정작업이 끝난 생천마 진액의 고분자물질이 나노화되어 인체에 쉽게 흡수되는 반면 천마의 유용성분들이 인체 친화적인 물질로 바뀌어 랑겔한스가 거부감을 없애는데 장점이 있고, 또한 에르고티오닌(Ergothioneine=ERG)이 다량 생성된 생물반응 후 발효추출물을 향장원료, 식품원료 및 의약원료에 활용할 수 있다.In other words, fermented microorganisms are added to the thawed drip process in a fermenter at 25 ° C. to 60 ° C. by primary fermentation, and secondly through lactic acid through liquid reaction in the bioreactor. It induces fermentation and undergoes a bioprocessing process that converts the macromolecule material from the raw horse to nanomaterials. The macromolecules of the raw cheonma juice after the 1st and 2nd bioprocessing work are nano-ized and easily absorbed by the human body, while the useful ingredients of the cheonma are changed to human-friendly materials, which has the advantage that Langelhans eliminates rejection. Fermentation extracts after bioreactions (Ergothioneine = ERG) are produced in large quantities can be used for cosmetic ingredients, food ingredients and pharmaceutical raw materials.
본 발명은 기재된 실시예에 한정되는 것은 아니고, 본 발명의 사상 및 범위를 벗어나지 않고 다양하게 수정 및 변형할 수 있음은 이 기술의 분야에서 통상의 지식을 가진 자에게 자명하다. 따라서 그러한 변형예 또는 수정예들은 본 발명의 특허청구범위에 속한다 해야 할 것이다.It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit and scope of the invention as defined by the appended claims. It is therefore intended that such variations and modifications fall within the scope of the appended claims.
Claims (6)
상기 제1단계의 건조물을 급속 동결한 다음, 발효조 내에서 해동드립하여 진액을 추출하는 제2단계;
상기 제2단계의 생천마 진액을 배양조 상에서 발효미생물과 증류수와 혼합한 다음, 발효에 필요한 질소원과 탄소원을 추가하여 혼합물을 생성하는 제3단계;
상기 제3단계의 혼합물을 생물반응기(bioreactor) 상에서 생물반응을 거쳐 액상화된 젖산발효산물을 생성하는 제4단계;
상기 제4단계의 젖산발효산물을 급속멸균장치(Outoclave)를 이용하여 발효미생물을 멸균하는 제5단계;
상기 제5단계의 젖산발효산물을 규조토 여과기를 이용하여 불순물을 제거한 다음, 가열하여 25~60브릭스(Brix)를 지니도록 농축하는 제6단계; 및
상기 제6단계의 발효추출물을 스프레이 드라이어(Spray dryer)를 이용하여 수분율 5~7%를 지니도록 건조하는 제7단계;를 포함하여 이루어지는 것을 특징으로 하는 해동드립을 이용한 생천마 발효추출물을 제조하는 방법.A first step of washing the raw horse as a main raw material and then drying it;
A second step of rapidly freezing the dried product of the first step and then extracting the lysate by thawing drip in a fermenter;
A third step of mixing the raw cheonma sake solution of the second step with the fermentation microorganism and distilled water in a culture tank, and then adding a nitrogen source and a carbon source necessary for fermentation to generate a mixture;
A fourth step of producing a liquefied lactic acid fermentation product through a bioreaction of the mixture of the third step on a bioreactor;
A fifth step of sterilizing the fermentation microorganism using the fourth step lactic acid fermentation product using an rapid sterilization apparatus (Outoclave);
A sixth step of removing impurities from the fermented lactic acid product of the fifth step by using a diatomaceous earth filter and then heating and concentrating to have 25 to 60 brix; And
The seventh step of drying the fermentation extract of the sixth step to have a moisture content of 5 ~ 7% by using a spray dryer (Spray dryer); to prepare a raw corn fermentation extract using a thaw drip characterized in that it comprises a Way.
상기 제2단계는 건조물을 -40℃~-70℃로 유지하여 4~30시간 급속 동결하고, 발효조 내에서 25℃~60℃로 유지하여 해동드립(drip)을 진행하는 것을 특징으로 하는 해동드립을 이용한 생천마 발효추출물을 제조하는 방법.The method of claim 1,
The second step is to freeze the dried product at -40 ℃ ~ -70 ℃ 4 to 30 hours rapid freezing, thawing drip (drip) characterized in that the defrost drip (drip) by maintaining at 25 ℃ ~ 60 ℃ in the fermenter Method of producing a raw corn horse fermented extract.
상기 제3단계는 생천마 진액에 발효미생물인 구름버섯(Coriolus versicolor), 꽃구름버섯(Stereum hirustum), 상황버섯(Phellinus linteus), 누룩곰팡이(Aspergillus oryzae), 말굽버섯(Fomes fomentarius), 동충하초(Coriolus sinensis), 바실러스(Bacillus)속, 락토바실러스(Lactobacillus)속을 그람(g)당 개체수가 의 개체수가 되도록 배양시켜 증류수와 혼합하여 pH 5.5~7을 지니도록 한 다음, 질소원과 탄소원 5~50중량%를 추가하여 혼합물을 생성하는 것을 특징으로 하는 해동드립을 이용한 생천마 발효추출물을 제조하는 방법.The method of claim 1,
In the third step, fermented microorganisms such as cloud mushroom (Coriolus versicolor), cloud mushroom (Stereum hirustum), mushroom mushroom (Phellinus linteus), yeast fungus (Aspergillus oryzae), horseshoe mushroom (Fomes fomentarius) Coriolus sinensis, Bacillus genus, Lactobacillus genus per gram (g) After culturing to the number of individuals to mix with distilled water to have a pH of 5.5 ~ 7, and then to add a nitrogen source and 5 to 50% by weight of a carbon source to prepare a raw corn fermentation extract using a thaw drip, characterized in that to produce a mixture Way.
상기 제3단계의 질소원은 미강, 보리가루, 밀기울 중에서 1종을 택일하고, 탄소원은 사카로스, 말로즈, 올리고당 중에서 1종을 택일하여 생물반응이 잘 이루어지도록 혼합한 것을 특징으로 하는 해동드립을 이용한 생천마 발효추출물을 제조하는 방법.The method of claim 1,
The nitrogen source of the third step is one selected from the rice bran, barley flour, bran, and the carbon source is selected from one of the saccharose, malose, oligosaccharide and thawed drip characterized in that the bioreaction is mixed well Method for preparing the raw corn horse fermentation extract.
상기 제4단계는 혼합물을 생물반응기의 온도 18℃~50℃와, pH 5.5~7을 유지하는 무압의 조건 하에서 2~60일간 생물반응으로 발효하여 액상화된 젖산발효산물을 생성하는 것을 특징으로 하는 해동드립을 이용한 생천마 발효추출물을 제조하는 방법.The method of claim 1,
In the fourth step, the mixture is fermented by bioreaction for 2 to 60 days under a pressureless condition of maintaining a temperature of 18 ° C. to 50 ° C. and a pH of 5.5 to 7 in the bioreactor to produce a liquefied lactic acid fermentation product. Method for producing fermented cheonnjang fermentation extract using thaw drip.
상기 제5단계는 젖산발효산물을 급속멸균장치(Outoclave)를 이용하여 121℃~132℃의 온도로 10~30분간 생물반응시 투입된 발효미생물을 멸균하는 것을 특징으로 하는 해동드립을 이용한 생천마 발효추출물을 제조하는 방법.The method of claim 1,
The fifth step is fermentation of live horses with thawed drip, characterized in that the fermentation microorganisms sterilized during fermentation of the lactic acid fermented product during the bioreaction for 10-30 minutes at a temperature of 121 ℃ ~ 132 ℃ using a rapid sterilization device (Outoclave) How to prepare an extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110102546A KR101335788B1 (en) | 2011-10-07 | 2011-10-07 | Method for preparing fermented extract of Gastrodiae elata by using of drip |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110102546A KR101335788B1 (en) | 2011-10-07 | 2011-10-07 | Method for preparing fermented extract of Gastrodiae elata by using of drip |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20130037959A KR20130037959A (en) | 2013-04-17 |
KR101335788B1 true KR101335788B1 (en) | 2013-12-02 |
Family
ID=48438780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110102546A Expired - Fee Related KR101335788B1 (en) | 2011-10-07 | 2011-10-07 | Method for preparing fermented extract of Gastrodiae elata by using of drip |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101335788B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102167812B1 (en) * | 2017-10-25 | 2020-10-20 | 주식회사 단정바이오 | Fermented product of sorghum-adzuki bean mixture for intestinal health and improvement effect of bowel |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010004103A (en) * | 1999-06-28 | 2001-01-15 | 류인덕 | Method of producing a malberryleaf health food by fermentation of lactic acid bacteria and yeast |
KR20060006753A (en) * | 2005-12-30 | 2006-01-19 | (주)필리엠에스피 | Manufacturing method of natural hair regrowth using microbial fermentation process and natural hair regrowth prepared by |
KR20100047354A (en) * | 2008-10-29 | 2010-05-10 | 송호엽 | Manufacturing method extracting Saponin (saponin) polysaccharide mineral vitamins by increasing the recovery rate of antioxidants such as saponin (saponin), saponin, saponin, etc. |
KR101015860B1 (en) | 2010-08-10 | 2011-02-23 | 김정임 | Anticancer composition containing cheonma fermentation broth as an active ingredient and method for preparing the same |
-
2011
- 2011-10-07 KR KR1020110102546A patent/KR101335788B1/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010004103A (en) * | 1999-06-28 | 2001-01-15 | 류인덕 | Method of producing a malberryleaf health food by fermentation of lactic acid bacteria and yeast |
KR20060006753A (en) * | 2005-12-30 | 2006-01-19 | (주)필리엠에스피 | Manufacturing method of natural hair regrowth using microbial fermentation process and natural hair regrowth prepared by |
KR20100047354A (en) * | 2008-10-29 | 2010-05-10 | 송호엽 | Manufacturing method extracting Saponin (saponin) polysaccharide mineral vitamins by increasing the recovery rate of antioxidants such as saponin (saponin), saponin, saponin, etc. |
KR101015860B1 (en) | 2010-08-10 | 2011-02-23 | 김정임 | Anticancer composition containing cheonma fermentation broth as an active ingredient and method for preparing the same |
Also Published As
Publication number | Publication date |
---|---|
KR20130037959A (en) | 2013-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9394513B2 (en) | Method for fermentation and cultivation, fermented plant extract, fermented plant extract powder, and composition containing the extract of fermented plant | |
KR101054041B1 (en) | Manufacturing method and composition for mass processing fermented products and fermented extracts using Hwangchil wood | |
CN105146614A (en) | Functional Chinese dwarf cherry seed ferment, ferment beverage and production method of ferment beverage | |
JP2011012048A (en) | Koji mold-fermented composition of citrus fruit rind | |
KR101238968B1 (en) | Method for preparing composition comprising fermented wild ginseng that contain ergothioneine | |
US10820612B2 (en) | Method for producing fermented bamboo extract and immunostimulating agent | |
KR101148513B1 (en) | Method for preparing producing an enrichment composition of ergothioneine from gastrodiae elata | |
KR101799424B1 (en) | Astragalus membranaceus Fermentation product and its manufacturing method | |
CN110495611A (en) | A kind of technique improving sea cucumber nutritional health effect | |
DK2560506T3 (en) | METHOD OF PRODUCING A FERMENTED natural materials | |
KR20080004515A (en) | Blood pressure lowering agents obtained by lactic acid bacteria culture | |
KR101045011B1 (en) | Method for preparing fermentation composition using vitamin tree | |
KR20130037956A (en) | Method for preparing composition comprising fermented by using of dendropanax morbifera | |
KR101335788B1 (en) | Method for preparing fermented extract of Gastrodiae elata by using of drip | |
CN106173736A (en) | A kind of method of Poria fermentation ferment processed | |
CN106616977A (en) | Preparation method of edible cudrania tricuspidata ferment | |
CN110791407B (en) | Black-changed red date vinegar and vinegar egg liquid prepared from same | |
CN106937731A (en) | Queen bee nit powder extracts and its preparation method and application | |
KR100937255B1 (en) | Fractionation method for low molecular weight bioactive black garlic concentrates by stepwise nano-filtration of mature black garlic | |
CN108354171A (en) | A kind of inoxidizability flavor purple yampi ferment and preparation method thereof | |
KR20130115521A (en) | Method for preparing composition comprising fermented by using of red pepper and by-products | |
TWI458438B (en) | Fermentation and culture methods, plant fermentation extracts, plant fermentation extract powders, and plant fermentation extract complexes | |
KR20160034009A (en) | Method of manufacturing liquefied fermentation product by using of Eastern prickly pear | |
HK1096119B (en) | Fermentation and culture method, fermented plant extract, fermented plant extract powder and composition containing the fermented plant extract | |
KR20130115522A (en) | Method for preparing composition comprising fermented by using of radish and radish greens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20111007 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20130313 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20130926 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20131126 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20131126 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20161125 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20161125 Start annual number: 4 End annual number: 4 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20180907 |